Aetna's 2027 Medicare plans introduce $0 copays for Tier 1 drugs and preventative screenings, signaling a strategic push to bolster CVS Health's insurance segment competitiveness.
CVS Health's Aetna subsidiary is strategically positioning its 2027 Medicare plans to drive member retention and acquisition through enhanced value propositions. By eliminating copays for essential services like Tier 1 drugs, vaccines, and preventative screenings, the company aims to improve health outcomes while potentially lowering long-term medical loss ratios.
Aetna's 2027 plans include $0 copays for annual physicals, colonoscopies, and mammograms when performed at in-network providers.
The program provides members with an annual Healthy Home Visit conducted by a licensed Signify Health professional at no additional copay cost.
CVS Health subsidiary Aetna has announced its 2027 Medicare plan lineup, emphasizing enhanced member value through zero-copay structures. The strategy targets increased access to care by eliminating costs for essential services, including Tier 1 drugs, vaccines, and preventative screenings.
The plans offer $0 copays for Tier 1 drugs, vaccines, and key preventative screenings like mammograms and colonoscopies to reduce out-of-pocket costs for members.